Optical sensors for monitoring dynamic changes of intracellular metabolite levels in mammalian cells.

Carnegie Institution for Science, Stanford, California, USA.
Nature Protocol (Impact Factor: 8.36). 11/2011; 6(11):1818-33. DOI: 10.1038/nprot.2011.392
Source: PubMed

ABSTRACT Knowledge of the in vivo levels, distribution and flux of ions and metabolites is crucial to our understanding of physiology in both healthy and diseased states. The quantitative analysis of the dynamics of ions and metabolites with subcellular resolution in vivo poses a major challenge for the analysis of metabolic processes. Genetically encoded Förster resonance energy transfer (FRET) sensors can be used for real-time in vivo detection of metabolites. FRET sensor proteins, for example, for glucose, can be targeted genetically to any cellular compartment, or even to subdomains (e.g., a membrane surface), by adding signal sequences or fusing the sensors to specific proteins. The sensors can be used for analyses in individual mammalian cells in culture, in tissue slices and in intact organisms. Applications include gene discovery, high-throughput drug screens or systematic analysis of regulatory networks affecting uptake, efflux and metabolism. Quantitative analyses obtained with the help of FRET sensors for glucose or other ions and metabolites provide valuable data for modeling of flux. Here we provide a detailed protocol for monitoring glucose levels in the cytosol of mammalian cell cultures through the use of FRET glucose sensors; moreover, the protocol can be used for other ions and metabolites and for analyses in other organisms, as has been successfully demonstrated in bacteria, yeast and even intact plants. The whole procedure typically takes ∼4 d including seeding and transfection of mammalian cells; the FRET-based analysis of transfected cells takes ∼5 h.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: A broad range of genetically-encoded fluorescence biosensors has been developed, allowing the detection of signaling intermediates and metabolites in real time. Many of these biosensors are based on Foerster Resonance Energy Transfer (FRET). The two biosensors of the well-known "Venus-flytrap" type exemplarily studied in this work are composed of a central sugar binding protein flanked by two green fluorescent protein derivatives, namely ECFP as well as Citrine and EYFP, respectively. In order to evaluate FRET-based biosensors as an in vivo tool for quantitative metabolite analyses, we have thoroughly studied the effects of pH, buffer salts, ionic strength, temperature and several intracellular metabolites on the signal intensity of both biosensors and both fluorescence proteins. Almost all micro-environmental variations led to considerably different FRET signals, because either the fluorescent proteins or the metabolite binding domains were affected by the tested parameters. This resulted not only in altered FRET ratios between the apo state and the saturated state but also in significant shifts of the apparent binding constant. This underlines the necessity of careful controls in order to allow reliable quantitative measurements in vivo.
    Journal of Biotechnology 08/2014; DOI:10.1016/j.jbiotec.2014.07.007 · 2.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We develop a class of polymer–inorganic hybrid microgels, comprising Ag nanoparticle cores covered by a poly(3-acrylamidophenylboronic acid-co-2-(dimethylamino)ethyl acrylate) [p(3-VAPBA-co-DMAEA)] gel shell, to demonstrate that the volume phase transition behaviour of poly(phenylboronic acid) gels can be tailored from exhibiting monotonous swelling to monotonous shrinking upon adding glucose at a physiological pH of 7.4, via varying the feeding ratio of monomers DMAEA (introducing positive charges by ionization) to 3-VAPBA (introducing negative charges through the formation of a glucose–boronate complex) in the synthesis. The counterbalance of the positive and negative charges at particular glucose concentrations is a key parameter to enable this tailoring. Accompanied by this tailoring, the photoluminescence of the hybrid microgels is tuned from glucose-responsive “turn-off” to “turn-on”, in which the latter displays an improved glucose-sensing performance in both artificial tear fluid (a model for low glucose concentrations) and urine (for high glucose concentrations).
    03/2014; 5(7). DOI:10.1039/C3PY01564E
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Detection of protein-protein interactions (PPIs) is important for understanding numerous processes in mammalian cells; however, existing PPI detection methods often give significant background signals. Here, we propose a novel PPI-detection method based on kinase-mediated growth induction of mammalian cells. In this method, target proteins are fused to the intracellular domain of c-kit (c-kit ICD) and expressed in interleukin-3-dependent mammalian cells. The PPI induces dimerization and activation of c-kit ICDs, which leads to cell growth in the absence of interleukin-3. Using this system, we successfully detected the ligand-dependent homo-interaction of FKBPF36V and hetero-interaction of FKBP and FRBT2098L, as well as the constitutive interaction between MDM2 and a known peptide inhibitor. Intriguingly, cells expressing high-affinity peptide chimeras are selected from the mixture of the cell populations dominantly expressing low-affinity peptide chimeras. These results indicate that this method can detect PPIs with low background levels and is suitable for peptide inhibitor screening.
    Scientific Reports 08/2014; 4:6127. DOI:10.1038/srep06127 · 5.08 Impact Factor

Full-text (2 Sources)

Available from
May 29, 2014